Ángela R. Zambrano

Researcher Next ID · RN-028829

Researcher · Medicine

Guayaquil, Colombia

Not currently recruitingFunding unknown

Research interests

Medicine

Head and Neck Cancer Studies

Esophageal Cancer Research and Treatment

Cancer Immunotherapy and Biomarkers

Gastric Cancer Management and Outcomes

Helicobacter pylori-related gastroenterology studies

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
The Lancet Oncology · 2024 · https://doi.org/10.1016/s1470-2045(24)00100-1
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
The Lancet Oncology · 2023 · https://doi.org/10.1016/s1470-2045(23)00469-2
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)32591-7
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)31257-1

No projects listed.